Stocks rise as investors await the start of earnings season — here's what to expect

U.S. stocks are slightly higher Friday, with the S&P 500 up more than 1% for the week and the Nasdaq up more than 1.5%, after a brief mid-morning dip following Trump’s Truth Social comments that U.S. talks with Iran will continue but the ceasefire is “OVER.” The bigger near-term catalyst is next week’s earnings deluge—JPMorgan, Goldman Sachs, Citigroup, Bank of America, and Wells Fargo kick off Tuesday—where market focus will be on capital markets strength (Goldman’s activity/backlog) and turnaround execution at Wells Fargo. The article also flags SK Hynix’s AI-memory strength as a sentiment driver and notes upcoming chip-complex and megacap earnings (Taiwan Semiconductor Thursday; Netflix Thursday after the close).

Analysis

This setup is less about direction and more about dispersion: with financials, healthcare, and semis all printing in a tight window, the market will reward the cleanest guide rather than the best headline EPS. Banks with capital-markets leverage should out-earn the group if underwriting and trading offset slower net-interest income, while balance-sheet-heavy lenders are more exposed to any sign that deposits are sticky and credit is normalizing more slowly than expected. That makes the first 24 hours after the releases a positioning event, not a fundamentals event.

The biggest second-order read-through is in semis. A strong response to memory/AI enthusiasm helps TSM and ASML only if it translates into capex, not just sentiment; ASML is the bottleneck beneficiary, but also the most vulnerable to any signal that foundry spending is being deferred. If TSM’s sales or capex guidance comes in merely in-line, the market could de-rate the whole AI supply chain because expectations have moved from demand recovery to durable supercycle.

Healthcare looks like a factor flow trade more than a sector crisis. JNJ has the best chance to convert execution into multiple support because investors are paying up for cash-flow visibility, while the group’s weakness makes the tape sensitive to any incremental proof of margin stability. Contrarian risk: if earnings are merely decent across the board, the crowded defensive underweight could unwind quickly over 1-3 weeks, especially in JNJ; the trade would fail if managements sound more cautious on 2H guidance or if bank reserve builds surprise to the upside.

Key Decisions for Investors

• Long WFC into earnings with a 1-2 week horizon: low expectations create the highest mean-reversion potential in the large-cap bank group, but keep a tight risk stop if NII or credit-cost guidance worsens.
• Pair trade: long GS / short BAC into bank earnings week. GS is better levered to capital-markets backlog and should show cleaner earnings quality; BAC is more exposed to rate-pressure and deposit beta. Falsify if trading and IB activity disappoints broadly.
• Buy TSM on any post-print weakness, with ASML as the delayed follow-through. The catalyst is capex guidance, not sales alone; if TSM implies disciplined spending, reduce quickly because equipment multiples can compress 5-10% in a day.
• Initiate a tactical long in JNJ ahead of the print or on a mild post-earnings pullback. The market is paying for stability, so the upside is modest but probability-weighted; thesis breaks if management tones down full-year operating-sales or EPS growth.
• Avoid chasing intraday geopolitics in the absence of energy exposure; the market is treating the Iran noise as a headline event, not a cash-flow event. Use any risk-off dip to add only if it is not accompanied by a deterioration in bank/TSM guidance.